BMY Stock Price Prediction From 2024 To 2030 – Bristol-Myers Squibb Company (NYSE: BMY) is a leading biopharmaceutical company with a focus on developing cutting-edge treatments for critical illnesses. With its main office located in New York, the company offers therapies for fibrosis, immunology, cancer, and cardiovascular diseases by fusing state-of-the-art research with a dedication to patient care and medical innovation.
About the Company – BMY
Bristol Myers Squibb (BMY) is a multinational biopharmaceutical firm whose goal is to find, create, and distribute cutting-edge medications that enable people to overcome life-threatening illnesses. The company, which was established in 1887, specializes in the study and treatment of fibrotic disease, cancer, cardiovascular disease, and immunology. Bristol Myers Squibb has a strong pipeline of prospective treatments and works to offer a varied range of disease-altering medications. The company combines the agility and entrepreneurial spirit of a biotech company with the reach and resources of a major pharmaceutical company.
Overview of BMY Stock Price
In 1972, Bristol-Myers Squibb Company (NYSE: BMY) held its initial public offering. Six stock splits occurred for Bristol-Myers Squibb (BMY): a 2:1 split in 1977, 1983, 1987, 1997, and 1999, as well as a 1000000:951777 split in 2001. 33.62 shares today are equal to one pre-1977 share.1. The stock price as of August 8, 2024, is $46.85.
- Previous Close -$48.24
- Open -$48.36
- Day’s Low – $47.81
- Day’s High – $48.79
- 52 Week Low – $39.35
- 52 WeekHigh – $63.41
- Volume – 4,868,445
- Market Cap – 97.558B
- Beta – 0.44
- EPS (TTM) – 3.25
- Yield – 2.40 (4.98%)
BMY Stock Price Prediction 2024 To 2030
The Bristol-Myers Squibb stock is expected to grow by $58.68 per year on average at the start of the following year, based on the firm’s growth during the previous ten years. Here is the Bristol-Myers Squibb stock forecast for each year through 2030 using the same methodology.
| Year | Stock Price Prediction |
| 2025 | $ 58.68 |
| 2026 | $ 69.26 |
| 2027 | $ 81.84 |
| 2028 | $ 93.43 |
| 2029 | $ 105.02 |
| 2030 | $119.62 |
How to purchase BMY Stock Price
Several buying and trading platforms, including facet Zerodha, Upstox, Groww, and Angel One, let you to purchase BMY Stock.
Peer Companies of BMY Stock
- Merck & Co.
- Novartis AG
- Ali Lily & Company
- GSK Plc.
- Roche Holding AG
Investor type & Ratios for BMY Stock
| % of Shares Held by All Insider | 0.11% |
| % of Shares Held by Institutions | 78.10% |
| % of Float Held by Institutions | 78.19% |
| Number of Institutions Holding Shares | 2,816 |
Our in-depth examination of the stock price projection for Bristol-Myers Squibb Company (NYSE: BMY) from 2024 to 2030 reveals strong and steady growth. By 2030, we expect the stock price will soar to $119.62.
In our advice, we took into account a number of factors, including both short- and long-term BMY price projections. We’ve also talked about the BMY ecosystem’s present condition and future development prospects.
